{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T21:11:12Z","timestamp":1769202672999,"version":"3.49.0"},"reference-count":34,"publisher":"BMJ","issue":"1","license":[{"start":{"date-parts":[[2020,3,11]],"date-time":"2020-03-11T00:00:00Z","timestamp":1583884800000},"content-version":"unspecified","delay-in-days":10,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100006484","name":"Vifor Pharma","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006484","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Open Heart"],"accepted":{"date-parts":[[2020,2,20]]},"published-print":{"date-parts":[[2020,3]]},"abstract":"<jats:sec>\n                  <jats:title>Objectives<\/jats:title>\n                  <jats:p>Iron deficiency (ID), with or without anaemia (IDA), is an important comorbidity in people with chronic heart failure (HF), but the prevalence and significance in those admitted with HF is uncertain. We assessed the prevalence of ID or IDA in adults (age \u226521 years) hospitalised with a primary diagnosis of HF, and examined key metrics associated with these secondary diagnoses.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>A retrospective cohort study of Hospital Episode Statistics describing all adults admitted to National Health Service (NHS) hospitals across England from April 2015 through March 2016 with primary diagnostic discharge coding as HF, with or without subsidiary coding for ID\/IDA.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>78\u2009805 adults were admitted to 177 NHS hospitals with primary coding as HF: 26\u2009530 (33.7%) with secondary coding for ID\/IDA, and 52\u2009275 (66.3%) without. Proportionately more patients coded ID\/IDA were admitted as emergencies (94.8% vs 87.6%; p&lt;0.0001). Tending to be older and female, they required a longer length of stay (15.8 vs 12.2 days; p&lt;0.0001), with higher <jats:italic>per capita<\/jats:italic> costs (\u00a33623 vs \u00a32918; p&lt;0.0001), the cumulative excess expenditure being \u00a321.5\u2009million. HF-related (8.2% vs 5.2%; p&lt;0.0001) and all-cause readmission rates (25.8% vs 17.7%; p&lt;0.05) at \u226430 days were greater in those with ID\/IDA against those without, and they manifested a small but statistically significant increased inpatient mortality (13.5%\u2009v 12.9%; p=0.009).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>For adults admitted to hospitals in England, principally with acute HF, ID\/IDA are significant comorbidities and associated with adverse outcomes, both for affected individuals, and the health economy.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1136\/openhrt-2019-001153","type":"journal-article","created":{"date-parts":[[2020,3,12]],"date-time":"2020-03-12T04:55:26Z","timestamp":1583988926000},"page":"e001153","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":20,"title":["Iron deficiency in 78 805 people admitted with heart failure across England: a retrospective cohort study"],"prefix":"10.1136","volume":"7","clinical-trial-number":[{"clinical-trial-number":"nct03733665","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct02937454","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct02642562","registry":"10.18810\/clinical-trials-gov"}],"author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7370-3485","authenticated-orcid":false,"given":"James M","family":"Beattie","sequence":"first","affiliation":[{"name":"Cicely Saunders Institute, King's College London, London, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9707-234X","authenticated-orcid":false,"given":"Rani","family":"Khatib","sequence":"additional","affiliation":[{"name":"Leeds Institute of Cardiovascular and Metabolic Medicine, University of Leeds, Leeds, UK"},{"name":"Departments of Cardiology and Medicines Management, Leeds Teaching Hospitals NHS Trust, Leeds, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1076-9289","authenticated-orcid":false,"given":"Ceri J","family":"Phillips","sequence":"additional","affiliation":[{"name":"College of Human and Health Sciences, Swansea University, Swansea, West Glamorgan, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simon G","family":"Williams","sequence":"additional","affiliation":[{"name":"North West Regional Heart Centre and Heart and Lung Transplant Unit, University Hospital of South Manchester, Manchester, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2020,3,11]]},"reference":[{"key":"2025081711083821000_7.1.e001153.1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(17)32520-5"},{"key":"2025081711083821000_7.1.e001153.2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ahj.2013.01.017"},{"key":"2025081711083821000_7.1.e001153.3","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1002\/ejhf.236","article-title":"Iron therapy for the treatment of iron deficiency in chronic heart failure: intravenous or oral?","volume":"17","author":"McDonagh","year":"2015","journal-title":"Eur J Heart Fail"},{"key":"2025081711083821000_7.1.e001153.4","doi-asserted-by":"publisher","DOI":"10.1093\/qjmed\/hcv049"},{"key":"2025081711083821000_7.1.e001153.5","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehl012"},{"key":"2025081711083821000_7.1.e001153.6","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2016.162917"},{"key":"2025081711083821000_7.1.e001153.7","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehw128"},{"key":"2025081711083821000_7.1.e001153.8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/00015385.2017.1351239","article-title":"Impact of iron deficiency on exercise capacity and outcome in heart failure with reduced, mid-range and preserved ejection fraction","volume":"73","author":"Martens","year":"2018","journal-title":"Acta Cardiol"},{"key":"2025081711083821000_7.1.e001153.9","unstructured":"National Institute for Health and Care Excellence . NG106. chronic heart failure in adults: diagnosis and management, 2018. Available: http:\/\/www.nice.org.uk\/guidance\/NG106 [Accessed 21 May 2019]."},{"key":"2025081711083821000_7.1.e001153.10","unstructured":"NHS Digital . Hospital Episode Statistics [Internet]. NHS Digital, 1 Trevelyan Square, Boar Lane, Leeds, LS1 6AE, UK. Available: http:\/\/content.digital.nhs.uk\/hes [Accessed 12 Nov 2019]."},{"key":"2025081711083821000_7.1.e001153.11","doi-asserted-by":"publisher","DOI":"10.1093\/pubmed\/fdr054"},{"key":"2025081711083821000_7.1.e001153.12","doi-asserted-by":"publisher","DOI":"10.1093\/pubmed\/fdv041"},{"key":"2025081711083821000_7.1.e001153.13","unstructured":"ICD 10 . International statistical classification of diseases and related health problems. 10th revision. 2nd edition. Geneva: World Health Organisation, 2010."},{"key":"2025081711083821000_7.1.e001153.14","unstructured":"Health and Social Care Information Centre, . \u201cNational ICD-10 Clinical Coding Standards\u201d, NHS Delen website. Published 2019 https:\/\/hscic.kahootz.com\/gf2.ti\/f\/762498\/46448165.2\/PDF\/- \/National_Coding_Standards_ICD10_reference_book_2019.pdf (accessed 7 Dec 2019)."},{"key":"2025081711083821000_7.1.e001153.15","doi-asserted-by":"publisher","DOI":"10.1093\/ije\/dyx015"},{"key":"2025081711083821000_7.1.e001153.16","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1002\/ehf2.12379","article-title":"Prevalence of underlying gastrointestinal malignancies in iron-deficient heart failure","volume":"6","author":"Martens","year":"2019","journal-title":"ESC Heart Fail"},{"key":"2025081711083821000_7.1.e001153.17","doi-asserted-by":"publisher","DOI":"10.1093\/ehjcvp\/pvu016"},{"key":"2025081711083821000_7.1.e001153.18","doi-asserted-by":"publisher","DOI":"10.1038\/nrcardio.2011.77"},{"key":"2025081711083821000_7.1.e001153.19","unstructured":"UNICEF, UNU WHO . Iron deficiency anaemia: assessment, prevention, and control. WHO\/NHD\/01.3. Geneva, Switzerland: World Health Organization, 2001."},{"key":"2025081711083821000_7.1.e001153.20","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2014.09.024"},{"key":"2025081711083821000_7.1.e001153.21","unstructured":"Healthcare Quality Improvement Partnership . National heart failure audit report April 2015-March 2016, 2017. Available: https:\/\/www.hqip.org.uk\/resource\/national-heart-failure-audit-2015-2016\/#.W0XRMC2ZOu4 [Accessed 20 June 2019]."},{"key":"2025081711083821000_7.1.e001153.22","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1016\/j.amjcard.2016.08.081","article-title":"Usefulness of Iron Deficiency Correction in Management of Patients With Heart Failure [from the Registry Analysis of Iron Deficiency-Heart Failure (RAID-HF) Registry]","volume":"118","author":"Wienbergen","year":"2016","journal-title":"Am J Cardiol"},{"key":"2025081711083821000_7.1.e001153.23","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1007\/s00392-016-1073-y","article-title":"Prevalence and clinical impact of iron deficiency and anaemia among outpatients with chronic heart failure: the PreP registry","volume":"106","author":"von Haehling","year":"2017","journal-title":"Clin Res Cardiol"},{"key":"2025081711083821000_7.1.e001153.24","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehs224"},{"key":"2025081711083821000_7.1.e001153.25","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1098-2825(1999)13:6<273::AID-JCLA4>3.0.CO;2-X"},{"key":"2025081711083821000_7.1.e001153.26","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehu235"},{"key":"2025081711083821000_7.1.e001153.27","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1002\/ejhf.837","article-title":"Iron status and inflammatory biomarkers in patients with acutely decompensated heart failure: early in-hospital phase and 30-day follow-up","volume":"19","author":"Van Aelst","year":"2017","journal-title":"Eur J Heart Fail"},{"key":"2025081711083821000_7.1.e001153.28","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2017.5427"},{"key":"2025081711083821000_7.1.e001153.29","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehu385"},{"key":"2025081711083821000_7.1.e001153.30","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1002\/ejhf.473","article-title":"Effects of intravenous iron therapy in iron-deficient patients with systolic heart failure: a meta-analysis of randomized controlled trials","volume":"18","author":"Jankowska","year":"2016","journal-title":"Eur J Heart Fail"},{"key":"2025081711083821000_7.1.e001153.31","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/j.jacc.2017.04.025","article-title":"ACC\/AHA\/HFSA focused update of the 2013 ACCF\/AHA guideline for the management of heart failure: a report of the American College of Cardiology\/American heart association Task force on clinical practice guidelines and the heart failure Society of America","volume":"2017","author":"Yancy","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"2025081711083821000_7.1.e001153.32","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0908355"},{"key":"2025081711083821000_7.1.e001153.33","doi-asserted-by":"crossref","DOI":"10.1136\/openhrt-2019-001012","article-title":"Iron deficiency in heart failure with preserved ejection fraction: a systematic review and meta-analysis","volume":"6","author":"Beale","year":"2019","journal-title":"Open Heart"},{"key":"2025081711083821000_7.1.e001153.34","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.118.030099"}],"container-title":["Open Heart"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/openhrt-2019-001153","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,17]],"date-time":"2025-08-17T18:08:50Z","timestamp":1755454130000},"score":1,"resource":{"primary":{"URL":"https:\/\/openheart.bmj.com\/lookup\/doi\/10.1136\/openhrt-2019-001153"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3]]},"references-count":34,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,3,11]]},"published-print":{"date-parts":[[2020,3]]}},"alternative-id":["10.1136\/openhrt-2019-001153"],"URL":"https:\/\/doi.org\/10.1136\/openhrt-2019-001153","relation":{},"ISSN":["2053-3624"],"issn-type":[{"value":"2053-3624","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,3]]}}}